全文获取类型
收费全文 | 2932篇 |
免费 | 230篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 94篇 |
妇产科学 | 118篇 |
基础医学 | 289篇 |
口腔科学 | 98篇 |
临床医学 | 250篇 |
内科学 | 612篇 |
皮肤病学 | 37篇 |
神经病学 | 92篇 |
特种医学 | 261篇 |
外科学 | 649篇 |
综合类 | 70篇 |
一般理论 | 2篇 |
预防医学 | 263篇 |
眼科学 | 35篇 |
药学 | 146篇 |
肿瘤学 | 137篇 |
出版年
2021年 | 35篇 |
2020年 | 23篇 |
2019年 | 30篇 |
2018年 | 37篇 |
2017年 | 38篇 |
2016年 | 38篇 |
2015年 | 52篇 |
2014年 | 64篇 |
2013年 | 87篇 |
2012年 | 107篇 |
2011年 | 113篇 |
2010年 | 107篇 |
2009年 | 87篇 |
2008年 | 89篇 |
2007年 | 133篇 |
2006年 | 125篇 |
2005年 | 96篇 |
2004年 | 86篇 |
2003年 | 90篇 |
2002年 | 79篇 |
2001年 | 75篇 |
2000年 | 69篇 |
1999年 | 83篇 |
1998年 | 69篇 |
1997年 | 78篇 |
1996年 | 80篇 |
1995年 | 72篇 |
1994年 | 72篇 |
1993年 | 53篇 |
1992年 | 71篇 |
1991年 | 76篇 |
1990年 | 75篇 |
1989年 | 70篇 |
1988年 | 75篇 |
1987年 | 54篇 |
1986年 | 78篇 |
1985年 | 79篇 |
1984年 | 41篇 |
1983年 | 44篇 |
1982年 | 28篇 |
1981年 | 22篇 |
1980年 | 16篇 |
1979年 | 28篇 |
1978年 | 18篇 |
1977年 | 21篇 |
1976年 | 26篇 |
1975年 | 18篇 |
1974年 | 23篇 |
1973年 | 16篇 |
1972年 | 24篇 |
排序方式: 共有3173条查询结果,搜索用时 15 毫秒
41.
42.
Susan Hutchinson-Phillips Graham A. Jamieson 《The International journal of clinical and experimental hypnosis》2013,61(1):84-113
The literature suggests that aspects of hypnotizability may be involved in the etiology and maintenance of self-defeating eating. However, interpretation of the published research findings has been complicated by the use of instruments that appear to have measured different or, at best, only related facets of the underlying constructs. This article reports relationships between weight, shape, dietary concerns, hypnotizability, dissociative capacity, and fantasy proneness. Implications for a key role for hypnosis in the treatment of eating behaviors, attitudes, and concerns are discussed. 相似文献
43.
44.
Thrombocytopoietic properties of oncostatin M 总被引:1,自引:2,他引:1
Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM in mice were investigated in culture and in vivo. Alone, OM did not induce megakaryocytic colony formation, but in combination with murine interleukin-3 (IL-3), OM markedly enhanced colony formation. The effects of OM on colony formation were similar to those of IL-6. OM alone augmented acetylcholinesterase in short-term marrow cultures. In normal mice, the administration of OM augmented platelet counts without increasing other circulating blood cell counts. The increment in counts exceeded that observed with IL-6. The kinetics of the OM response suggested that maximal increases in platelets occurred 3 days after the cessation of OM administration, irrespective of the duration of administration. In irradiated mice, OM administration accelerated platelet recovery and prevented the decrease in red blood cells observed in irradiated control animals. The data show that OM behaves as a megakaryocytic maturation factor in vitro and augments platelet production in vivo. Based on these animal data, OM may have potential clinical utility as a thrombocytopoietic agent. 相似文献
45.
46.
47.
48.
Totally endoscopic Ivor Lewis esophagectomy 总被引:4,自引:4,他引:4
Esophagectomy is associated with significant risks of perioperative morbidity and mortality, as well as prolonged convalescence
due to effects of the incisions used for conventional surgical access. Because the outcome of this procedure is palliative
in the majority of patients, it is possible that laparoscopic techniques could improve initial postoperative outcomes and
therefore make surgery more acceptable for patients with esophageal cancer. A new technique is described for Ivor Lewis esophagectomy,
which incorporates a hand-assisted laparoscopic approach for gastric mobilization and a thoracoscopic approach for esophageal
dissection and anastomosis. Initial experience in two patients has been encouraging, with postoperative hospital stay and
convalescence shortened.
Received: 17 December 1997/Accepted: 18 March 1998 相似文献
49.
W R Eric Jamieson M A Marchand C L Pelletier R Norton M Pellerin T W Dubiel M R Aupart W J Daenen M P Holden T E David E A Ryba W N Anderson 《The Journal of thoracic and cardiovascular surgery》1999,118(2):297-304
BACKGROUND: Bioprostheses preserved with glutaraldehyde, both porcine and pericardial, have been available as second-generation prostheses for valve replacement surgery. The performance with regard to structural valve deterioration with the Carpentier-Edwards supra-annular (CE-SAV) porcine bioprosthesis and the Carpentier-Edwards Perimount (CE-P) pericardial bioprosthesis (Baxter Healthcare Corp, Edwards Division, Santa Ana, Calif) was evaluated to determine whether there was a difference in mitral valve replacement. METHODS: The CE-SAV bioprosthesis was implanted in 1266 overall mitral valve replacements (isolated mitral, 1066; mitral in multiple, 200) and the CE-P bioprosthesis in 429 overall mitral valve replacements (isolated mitral, 328; mitral in multiple, 101). The mean age of the CE-SAV population was 64.2 +/- 12.2 years and that of the CE-P population, 60.7 +/- 11.7 years (P =.0001). For the study, structural valve deterioration was diagnosed at reoperation for explantation. RESULTS: The freedom from structural valve deterioration was evaluated to 10 years, and the freedom rates reported are at 10 years. For the overall mitral valve replacement groups, the actuarial freedom from deterioration was significant (P =.0001): CE-P > CE-SAV for 40 years or younger, 80% versus 60%; 41 to 50 years, 91% versus 61%; 51 to 60 years, 84% versus 69%; 61 to 70 years, 95% versus 75%. The older than 70-year group was 100% versus 92% (no significant difference). The actual freedom from structural valve deterioration also demonstrated the same pattern at 10 years: 40 years or younger, CE-P 82% versus CE-SAV 68%; 41 to 50 years, 92% versus 70%; 51 to 60 years, 90% versus 80%; 61 to 70 years, 97% versus 88%; and older than 70 years, 100% versus 97%. The independent risk factors of structural valve deterioration for the overall mitral valve replacement group were age and age groups and prosthesis type (CE-SAV > CE-P). The prosthesis type either in isolated replacement or in multiple replacement was not predictive of structural valve deterioration. The pathology of structural valve deterioration was different: 70% of CE-P failures were due to calcification and 57% of CE-SAV failures were due to combined calcification and leaflet tear. CONCLUSION: The actuarial and actual freedom from structural valve deterioration, diagnosed at reoperation, is greater at 10 years for CE-P than for CE-SAV bioprostheses. The mode of failure is different, and the cause remains obscure. Long-term evaluation is recommended, because the different modes of failure may alter the clinical performance by 15 and 20 years. 相似文献
50.